Kayne Anderson Rudnick Investment Management Portfolio holdings
AUM
$41.9B
1-Year Return
15.28%
This Quarter Return
-3.57%
1 Year Return
+15.28%
3 Year Return
+74.75%
5 Year Return
+124.58%
10 Year Return
+522.55%
AUM
$41B
AUM Growth
-$2.17B
(-5%)
Cap. Flow
+$149M
Cap. Flow
% of AUM
0.36%
Top 10 Holdings %
Top 10 Hldgs %
19.48%
Holding
1,028
New
72
Increased
321
Reduced
327
Closed
30
Top Buys
| 1 |
BJs Wholesale Club
BJ
|
$226M |
| 2 |
Choice Hotels
CHH
|
$213M |
| 3 |
Triumph Financial, Inc.
TFIN
|
$155M |
| 4 |
Universal Display
OLED
|
$128M |
| 5 |
Align Technology
ALGN
|
$115M |
Top Sells
| 1 |
ANSS
Ansys
ANSS
|
$220M |
| 2 |
Interactive Brokers
IBKR
|
$166M |
| 3 |
Dolby
DLB
|
$124M |
| 4 |
Emcor
EME
|
$118M |
| 5 |
Manhattan Associates
MANH
|
$116M |
Sector Composition
| 1 | Industrials | 32.09% |
| 2 | Technology | 19.8% |
| 3 | Financials | 18.96% |
| 4 | Consumer Discretionary | 10.82% |
| 5 | Healthcare | 7.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
376
American Homes 4 Rent
AMH
$12.9B
| $1.33M | ﹤0.01% |
35,921
-854
| -2% | -$31.7K |
|
377
Vanguard Information Technology ETF
VGT
$99.9B
| $1.26M | ﹤0.01% |
2,192
| – | – |
|
378
Equinix
EQIX
$75.7B
| $1.24M | ﹤0.01% |
1,643
-38
| -2% | -$28.8K |
|
379
CVS Health
CVS
$93.6B
| $1.22M | ﹤0.01% |
20,609
-60,481
| -75% | -$3.57M |
|
380
Bristol-Myers Squibb
BMY
$96B
| $1.19M | ﹤0.01% |
28,668
-33,946
| -54% | -$1.41M |
|
381
L3Harris
LHX
$51B
| $1.19M | ﹤0.01% |
5,282
+4
| +0.1% | +$898 |
|
382
Vanguard Growth ETF
VUG
$186B
| $1.17M | ﹤0.01% |
3,130
+248
| +9% | +$92.7K |
|
383
Costco
COST
$427B
| $1.15M | ﹤0.01% |
1,356
+156
| +13% | +$133K |
|
384
Exxon Mobil
XOM
$466B
| $1.12M | ﹤0.01% |
9,765
+1,737
| +22% | +$200K |
|
385
DTE Energy
DTE
$28.4B
| $1.12M | ﹤0.01% |
10,121
+7,709
| +320% | +$856K |
|
386
iShares MSCI Japan ETF
EWJ
$15.5B
| $1.11M | ﹤0.01% |
16,297
-539
| -3% | -$36.7K |
|
387
CF Industries
CF
$13.7B
| $1.1M | ﹤0.01% |
14,774
+11,287
| +324% | +$837K |
|
388
Novartis
NVS
$251B
| $1.09M | ﹤0.01% |
10,225
-369
| -3% | -$39.3K |
|
|
WBA
389
DELISTED
Walgreens Boots Alliance
WBA
| $1.03M | ﹤0.01% |
85,192
+58,281
| +217% | +$705K |
|
390
Hershey
HSY
$37.6B
| $1.03M | ﹤0.01% |
5,600
| – | – |
|
391
MarketAxess Holdings
MKTX
$7.01B
| $1.01M | ﹤0.01% |
5,042
+1,079
| +27% | +$216K |
|
392
iShares Biotechnology ETF
IBB
$5.8B
| $991K | ﹤0.01% |
7,220
-67
| -0.9% | -$9.2K |
|
393
iShares MSCI EAFE Min Vol Factor ETF
EFAV
$5.42B
| $983K | ﹤0.01% |
14,205
-9,686
| -41% | -$670K |
|
394
Woodside Energy
WDS
$31.6B
| $959K | ﹤0.01% |
50,957
+7,828
| +18% | +$147K |
|
395
Texas Pacific Land
TPL
$20.4B
| $956K | ﹤0.01% |
1,302
| – | – |
|
396
Celanese
CE
$5.34B
| $955K | ﹤0.01% |
7,080
+5,360
| +312% | +$723K |
|
397
iShares US Healthcare ETF
IYH
$2.77B
| $940K | ﹤0.01% |
15,333
+5
| +0% | +$306 |
|
398
Procore
PCOR
$10.5B
| $928K | ﹤0.01% |
14,000
| – | – |
|
399
Dover
DOV
$24.4B
| $902K | ﹤0.01% |
5,000
| – | – |
|
400
iShares S&P Mid-Cap 400 Growth ETF
IJK
$9.22B
| $891K | ﹤0.01% |
10,112
+109
| +1% | +$9.6K |
|